Bone marrow-derived mesenchymal stem cells toward treatment of retinitis pigmentosa
The aim of this study is to evaluate the safety and efficacy of bone marrow-derived mesenchymal stem cell transplantation in treating retinitis pigmentosa.
Read More
No additional information regarding therapeutic cells was provided by the sponsor.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells toward treatment of retinitis pigmentosa